[New treatment of heart failure. Angiotensin II receptor blockaders show promising results in an extensive study].
Dahlström
Ulf
U
Kardiologiska kliniken, Universitetssjukhuset i Linköping. ulf.dahlstrom@lio.se
D057912:Angiotensin II Type 2 Receptor Blockers; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013777:Tetrazoles / Q000627:therapeutic use*
D057912:Angiotensin II Type 2 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan